By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Enanta Pharmaceuticals, Inc. 

500 Arsenal Street

Watertown  Massachusetts  02472  U.S.A.
Phone: 617-607-0800 Fax: 617-607-0530


SEARCH JOBS


Industry
Pharmaceutical






Company News
Enanta Pharmaceuticals, Inc. Reports Financial Results For Its Fiscal Second Quarter Ended March 31, 2015 5/7/2015 12:54:16 PM
Enanta Pharmaceuticals, Inc. To Present At The Deutsche Bank (DB) 40th Annual Healthcare Conference 4/28/2015 11:54:34 AM
Enanta Pharmaceuticals, Inc. To Host Conference Call To Discuss Financial Results For The Fiscal Second Quarter And Six-Months Ended March 31, 2015 4/27/2015 11:35:22 AM
Enanta Pharmaceuticals, Inc. Announces Preliminary Data From AbbVie (ABBV)’s Phase 3b RUBY-I Study In Chronic Hepatitis C Patients With Renal Impairment Presented At The International Liver Congress 2015 4/27/2015 11:04:52 AM
Enanta Pharmaceuticals, Inc. Announces FDA Grants Priority Review For AbbVie (ABBV)’s Investigational, All-Oral, Interferon-Free Treatment Regimen For Genotype 4 Chronic Hepatitis C Infection 4/23/2015 8:37:41 AM
Enanta Pharmaceuticals, Inc. Announces AbbVie (ABBV)’s Investigational Treatment Regimen For Genotype 1 Chronic Hepatitis C Granted Priority Review In Japan 4/16/2015 11:10:20 AM
Enanta Pharmaceuticals, Inc. Announces Data Presentations On Regimens Containing Protease Inhibitors Paritaprevir And ABT-493 At The International Liver Congress 2015 4/8/2015 9:53:10 AM
Enanta Pharmaceuticals, Inc. To Present At Barclays Global Healthcare Conference 3/4/2015 11:11:03 AM
Enanta Pharmaceuticals, Inc. Announces JAMA Publication Of Results From AbbVie (ABBV)’s Study Of VIEKIRA PAK™ (Ombitasvir, Paritaprevir, Ritonavir Tablets; Dasabuvir Tablets) In Chronic Hepatitis C Patients With HIV-1 Co-Infection (TURQUOISE-I) 2/23/2015 11:21:14 AM
Enanta Pharmaceuticals, Inc. Announces AbbVie (ABBV) Submits New Drug Application To The Japanese Ministry Of Health, Labour And Welfare For Its Investigational, All-Oral, Treatment For Chronic Hepatitis C 2/12/2015 11:42:00 AM
12345678910
//-->